NASDAQ:YTEN - Yield10 Bioscience Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$1.43 +0.02 (+1.42 %)
(As of 10/22/2018 04:00 PM ET)
Previous Close$1.41
Today's Range$1.37 - $1.45
52-Week Range$1.12 - $8.67
Volume36,845 shs
Average Volume455,673 shs
Market Capitalization$14.12 million
P/E Ratio-0.43
Dividend YieldN/A
Beta3.16
Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing disruptive technologies for enhancing crop yield in the United States and Canada. The company, through its Smart Carbon Grid for Crops and T3 platforms, is involved in improving fundamental crop yield through enhanced photosynthetic carbon capture, as well as increased carbon utilization efficiency to increase seed yield. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was founded in 1992 and is headquartered in Woburn, Massachusetts.

Receive YTEN News and Ratings via Email

Sign-up to receive the latest news and ratings for YTEN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Miscellaneous plastics products
Sub-IndustryN/A
SectorConsumer Staples
SymbolNASDAQ:YTEN
CUSIPN/A
Phone617-583-1700

Debt

Debt-to-Equity Ratio0.10
Current Ratio6.82
Quick Ratio6.82

Price-To-Earnings

Trailing P/E Ratio-0.43
Forward P/E Ratio-1.54
P/E GrowthN/A

Sales & Book Value

Annual Sales$940,000.00
Price / Sales15.23
Cash FlowN/A
Price / CashN/A
Book Value$1.48 per share
Price / Book0.97

Profitability

EPS (Most Recent Fiscal Year)($3.29)
Net Income$-9,390,000.00
Net Margins-1,377.53%
Return on Equity-101.61%
Return on Assets-76.35%

Miscellaneous

Employees20
Outstanding Shares10,010,000
Market Cap$14.12 million

Yield10 Bioscience (NASDAQ:YTEN) Frequently Asked Questions

What is Yield10 Bioscience's stock symbol?

Yield10 Bioscience trades on the NASDAQ under the ticker symbol "YTEN."

When did Yield10 Bioscience's stock split? How did Yield10 Bioscience's stock split work?

Yield10 Bioscience shares reverse split on Tuesday, May 30th 2017. The 1-10 reverse split was announced on Friday, May 26th 2017. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 26th 2017. An investor that had 100 shares of Yield10 Bioscience stock prior to the reverse split would have 10 shares after the split.

How were Yield10 Bioscience's earnings last quarter?

Yield10 Bioscience Inc (NASDAQ:YTEN) issued its quarterly earnings results on Thursday, August, 9th. The specialty chemicals company reported ($0.24) EPS for the quarter, topping the consensus estimate of ($0.27) by $0.03. The specialty chemicals company had revenue of $0.29 million for the quarter. Yield10 Bioscience had a negative return on equity of 101.61% and a negative net margin of 1,377.53%. View Yield10 Bioscience's Earnings History.

When is Yield10 Bioscience's next earnings date?

Yield10 Bioscience is scheduled to release their next quarterly earnings announcement on Thursday, November 8th 2018. View Earnings Estimates for Yield10 Bioscience.

What price target have analysts set for YTEN?

1 brokers have issued 1-year price objectives for Yield10 Bioscience's stock. Their forecasts range from $7.00 to $7.00. On average, they expect Yield10 Bioscience's stock price to reach $7.00 in the next twelve months. This suggests a possible upside of 389.5% from the stock's current price. View Analyst Price Targets for Yield10 Bioscience.

What is the consensus analysts' recommendation for Yield10 Bioscience?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Yield10 Bioscience in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Yield10 Bioscience.

Who are some of Yield10 Bioscience's key competitors?

Who are Yield10 Bioscience's key executives?

Yield10 Bioscience's management team includes the folowing people:
  • Dr. Oliver P. Peoples, Co-Founder, Pres, CEO & Director (Age 60)
  • Dr. Anthony J. Sinskey, Co-Founder & Director (Age 78)
  • Dr. Kristi Snell, VP of Research & Chief Science Officer (Age 50)
  • Ms. Lynne H. Brum, VP of Planning & Communications and Sec. (Age 54)
  • Mr. Charles B. Haaser, VP of Fin., Chief Accounting Officer & Treasurer (Age 62)

How do I buy shares of Yield10 Bioscience?

Shares of YTEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Yield10 Bioscience's stock price today?

One share of YTEN stock can currently be purchased for approximately $1.43.

How big of a company is Yield10 Bioscience?

Yield10 Bioscience has a market capitalization of $14.12 million and generates $940,000.00 in revenue each year. The specialty chemicals company earns $-9,390,000.00 in net income (profit) each year or ($3.29) on an earnings per share basis. Yield10 Bioscience employs 20 workers across the globe.

What is Yield10 Bioscience's official website?

The official website for Yield10 Bioscience is http://www.yield10bio.com.

How can I contact Yield10 Bioscience?

Yield10 Bioscience's mailing address is 19 PRESIDENTIAL WAY, WOBURN MA, 01801. The specialty chemicals company can be reached via phone at 617-583-1700 or via email at [email protected]


MarketBeat Community Rating for Yield10 Bioscience (NASDAQ YTEN)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  123 (Vote Outperform)
Underperform Votes:  151 (Vote Underperform)
Total Votes:  274
MarketBeat's community ratings are surveys of what our community members think about Yield10 Bioscience and other stocks. Vote "Outperform" if you believe YTEN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe YTEN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel